诊断学理论与实践 ›› 2021, Vol. 20 ›› Issue (02): 201-206.doi: 10.16150/j.1671-2870.2021.02.015
收稿日期:
2021-03-01
出版日期:
2021-04-25
发布日期:
2022-06-28
通讯作者:
曹久妹
E-mail:cjm11261@rjh.com.cn
基金资助:
WU Jie, FENG Yuanyuan, REN Yan, CAO Jiumei()
Received:
2021-03-01
Online:
2021-04-25
Published:
2022-06-28
Contact:
CAO Jiumei
E-mail:cjm11261@rjh.com.cn
摘要:
目的:探讨高龄老年人群(≥75岁)发生冠心病的主要危险因素及构建相应的诊断模型。方法:回顾分析上海交通大学医学院附属瑞金医院2018年6月至2019年12月期间拟诊冠心病而接受冠状动脉造影(coronary angiography,CAG)检查的高龄老年(≥75岁)患者548例,根据CAG结果分为冠心病组及对照组,采用多因素Logistic回归模型分析其危险因素,并用受试者操作特征(receiver operator characteristic,ROC)曲线评价这些因素对高龄老年人发生冠心病的预测价值。结果:对冠心病组及对照组进行基线分析后,构建多因素Logistic回归分析模型。多因素Logistic回归分析结果提示,肌钙蛋白I 水平升高[优势比(odds ratio,OR)=6.828,95%置信区间(confidence interval,CI)为 3.834~12.160,P<0.001)、颈动脉斑块形成(OR=3.440,95%CI为1.780~6.650,P<0.001)、糖化血红蛋白水平升高(OR=1.532,95%CI为1.182~1.987,P=0.001)和白细胞计数升高(OR=1.187,95%CI为1.027~1.371,P=0.021)是高龄老年人罹患冠心病的危险因素,而女性(OR=0.329,95%CI为0.201~0.538,P<0.001)、直接胆红素水平升高(OR=0.800,95%CI为0.679~0.942,P=0.008)、血红蛋白水平升高(OR=0.976,95%CI为0.960~0.992,P=0.003)为保护因素。根据以上7个因素构建ROC曲线的曲线下面积为0.825(P<0.05),显示其诊断效能良好。结论:与冠心病全人群的危险因素(如糖尿病、高血压、吸烟、高脂血症、肥胖、高同型半胱氨酸血症)不同,本研究发现肌钙蛋白I水平升高、颈动脉斑块形成是高龄老年人发生冠心病的主要危险因素,而女性则是高龄老年人群发生冠心病潜在的保护因素。建立相应的ROC曲线诊断模型,从拟诊冠心病患者人群中识别冠心病高危患者,可减少过度使用CAG检查。
中图分类号:
吴洁, 冯媛媛, 任妍, 曹久妹. 基于冠状动脉造影检查的高龄老年人群发生冠心病的危险因素调查及相应诊断模型的建立[J]. 诊断学理论与实践, 2021, 20(02): 201-206.
WU Jie, FENG Yuanyuan, REN Yan, CAO Jiumei. Survey of risk factors of coronary heart disease in elderly patients with coronary angiography and establishment of relevant diagnostic model[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 201-206.
表1
冠心病组与对照组的一般情况比较 [n(%)]
参数 | 对照组(n=140) | 冠心病组(n=408) | P值 |
---|---|---|---|
性别 | <0.001 | ||
男 | 51(36.4) | 235(57.6) | |
女 | 89(63.6) | 173(42.4) | |
年龄(岁) | 79.8±3.8 | 79.3±3.8 | 0.126 |
BMI(kg/m2) | 0.397 | ||
BMI<25 | 85(60.7) | 264(64.7) | |
BMI≥25 | 55(39.3) | 144(35.3) | |
吸烟史 | 20(14.3) | 101(24.8) | 0.010 |
饮酒史 | 14(10.0) | 77(18.9) | 0.015 |
疾病史 | |||
高血压 | 97(69.3) | 307(75.2) | 0.167 |
糖尿病 | 30(21.4) | 110(27.0) | 0.195 |
脑梗死 | 9(6.4) | 41(10.0) | 0.199 |
心律失常 | 8(5.7) | 12(2.9) | 0.131 |
主诉 | |||
胸闷 | 96(68.6) | 241(59.1) | 0.046 |
胸痛 | 42(30.0) | 151(37.0) | 0.134 |
心悸 | 32(22.9) | 55(13.5) | 0.009 |
腹痛 | 0(0.0) | 1(0.2) | 0.558 |
表2
冠心病组与对照组的生化指标比较[(n)%,$\bar{x}±s$]
指标 | 对照组(n=140) | 冠心病组(n=408) | P值 |
---|---|---|---|
白细胞计数(×109/L) | 5.61±1.57 | 6.57±2.09 | <0.001 |
血红蛋白(g/L) | 128.06±15.30 | 122.87±16.77 | 0.001 |
C反应蛋白[n(%)] | 0.002 | ||
正常(<10 mg/L) | 130(92.9) | 333(81.6) | |
异常(≥10 mg/L) | 10(7.1) | 75(18.4) | |
谷丙转氨酶(IU/L) | 20.96±15.76 | 22.58±17.76 | 0.076 |
谷草转氨酶(IU/L) | 24.64±11.45 | 28.13±25.10 | 0.377 |
总胆红素(mmol/L) | 14.91±6.21 | 13.91±5.38 | 0.068 |
直接胆红素(mmol/L) | 2.94±1.78 | 2.62±1.19 | 0.048 |
肌酐(μmol/L) | 82.37±26.06 | 88.51±28.86 | 0.027 |
尿酸(μmol/L) | 341.19±87.98 | 339.07±100.36 | 0.825 |
CK-MB[n(%)] | <0.001 | ||
正常(<4 ng/mL) | 127(90.7) | 301(73.8) | |
异常(≥4 ng/mL) | 13(9.3) | 107(26.2) | |
肌钙蛋白I [n(%)] | <0.001 | ||
正常(<0.04 ng/mL) | 122(87.1) | 184(45.1) | |
异常(≥0.04 ng/mL) | 18(12.9) | 224(54.9) | |
糖化血红蛋白(%) | 6.0±0.9 | 6.4±1.1 | <0.001 |
D-二聚体定量[n(%)] | 0.618 | ||
正常(<0.55 mg/L) | 88(62.9) | 266(65.2) | |
异常(≥0.55 mg/L) | 52(37.1) | 142(34.8) | |
总胆固醇(mmol/L) | 4.02±0.98 | 4.08±1.00 | 0.549 |
甘油三酯(mmol/L) | 1.37±0.92 | 1.35±0.67 | 0.848 |
低密度脂蛋白胆固醇(mmol/L) | 1.51±1.05 | 1.61±1.06 | 0.345 |
高密度脂蛋白胆固醇(mmol/L) | 1.31±0.32 | 1.22±0.31 | 0.005 |
表4
多因素Logistic回归模型分析结果
影响因素 | B | S.E. | Wald | OR (95%CI) | P值 |
---|---|---|---|---|---|
白细胞计数 | 0.171 | 0.074 | 5.367 | 1.187(1.027~1.371) | 0.021 |
糖化血红蛋白 | 0.427 | 0.133 | 10.372 | 1.532(1.182~1.987) | 0.001 |
血红蛋白 | -0.024 | 0.008 | 8.755 | 0.976(0.960~0.992) | 0.003 |
直接胆红素 | -0.224 | 0.084 | 7.129 | 0.800(0.679~0.942) | 0.008 |
女性 | -1.112 | 0.251 | 19.659 | 0.329(0.201~0.538) | <0.001 |
颈动脉斑块形成 | 1.236 | 0.336 | 13.503 | 3.440(1.780~6.650) | <0.001 |
肌钙蛋白I | 1.921 | 0.294 | 42.571 | 6.828(3.834~12.160) | <0.001 |
[1] |
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 di-seases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017, 390(10100):1211-1259.
doi: 10.1016/S0140-6736(17)32154-2 URL |
[2] | Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association[J]. Circulation, 2017, 135(10):e146-e603. |
[3] |
Gheorghe A, Griffiths U, Murphy A, et al. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review[J]. BMC Public Health, 2018, 18(1):975.
doi: 10.1186/s12889-018-5806-x pmid: 30081871 |
[4] | 马丽媛, 吴亚哲, 陈伟伟. 中国心血管病报告2018要点介绍[J]. 中华高血压杂志, 2019, 27(8):712-716. |
[5] |
Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions[J]. Circulation, 1999, 99(17):2345-2357.
pmid: 10226103 |
[6] |
Hanrahan MT, O'Flynn AM, McHugh SM, et al. Appropriate use of elective coronary angiography in patients with suspected stable coronary artery disease[J]. Ir J Med Sci, 2019, 188(3):807-813.
doi: 10.1007/s11845-018-1953-4 URL |
[7] |
Lian D, Liu Y, Liu YH, et al. Pre-procedural risk score of contrast-induced nephropathy in elderly patients undergoing elective coronary angiography[J]. Int Heart J, 2017, 58(2):197-204.
doi: 10.1536/ihj.16-129 pmid: 28320991 |
[8] |
Gudnadottir GS, James SK, Andersen K, et al. Outcomes after STEMI in old multimorbid patients with complex health needs and the effect of invasive management[J]. Am Heart J, 2019, 211:11-21.
doi: S0002-8703(19)30019-5 pmid: 30831330 |
[9] |
Pizzi C, Xhyheri B, Costa GM, et al. Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: a meta-analysis[J]. J Am Heart Assoc, 2016, 5(12):e004185.
doi: 10.1161/JAHA.116.004185 URL |
[10] |
Bai MF, Wang X. Risk factors associated with coronary heart disease in women: a systematic review[J]. Herz, 2020, 45(Suppl 1):52-57.
doi: 10.1007/s00059-019-4835-2 URL |
[11] |
Garshick MS, Vaidean GD, Vani A, et al. Cardiovascular risk factor control and lifestyle factors in young to middle-aged adults with newly diagnosed obstructive coronary artery disease[J]. Cardiology, 2019, 142(2):83-90.
doi: 10.1159/000498891 pmid: 31079098 |
[12] |
Peltzer S, Hellstern M, Genske A, et al. Health literacy in persons at risk of and patients with coronary heart di-sease: a systematic review[J]. Soc Sci Med, 2020, 245:112711.
doi: 10.1016/j.socscimed.2019.112711 URL |
[13] | Boos CJ, de Villiers N, Dyball D, et al. The relationship between military combat and cardiovascular risk: a systematic review and meta-analysis[J]. Int J Vasc Med, 2019, 2019:9849465. |
[14] |
Garg P, Morris P, Fazlanie AL, et al. Cardiac biomarkers of acute coronary syndrome: from history to high-sensiti-vity cardiac troponin[J]. Intern Emerg Med, 2017, 12(2):147-155.
doi: 10.1007/s11739-017-1612-1 URL |
[15] | Hammarsten O, Mair J, Möckel M, et al. Possible me-chanisms behind cardiac troponin elevations[J]. Biomar-kers, 2018, 23(8):725-734. |
[16] | He J, Chen P, Luo Y, et al. Relationship between the maximum carotid plaque area and the severity of coronary atherosclerosis[J]. Int Angiol, 2018, 37(4):300-309. |
[17] |
Mantella LE, Colledanchise KN, Hétu MF, et al. Carotid intraplaque neovascularization predicts coronary artery disease and cardiovascular events[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(11):1239-1247.
doi: 10.1093/ehjci/jez070 pmid: 31621834 |
[18] |
Wang WT, Hsu PF, Lin CC, et al. Hemoglobin A1C le-vels are independently associated with the risk of coronary atherosclerotic plaques in patients without diabetes: a cross-sectional study[J]. J Atheroscler Thromb, 2020, 27(8):789-800.
doi: 10.5551/jat.51425 URL |
[19] |
Leong A, Chen J, Wheeler E, et al. Mendelian rando-mization analysis of hemoglobin A 1c as a risk factor for coronary artery disease[J]. Diabetes Care, 2019, 42(7):1202-1208.
doi: 10.2337/dc18-1712 URL |
[20] |
Ewid M, Sherif H, Billah SMB, et al. Glycated hemoglobin predicts coronary artery disease in non-diabetic adults[J]. BMC Cardiovasc Disord, 2019, 19(1):309.
doi: 10.1186/s12872-019-01302-5 URL |
[21] |
Kristono GA, Holley AS, Harding SA, et al. White blood cell subtypes as predictors of adverse cardiac events[J]. Coron Artery Dis, 2020, 31(5):446-450.
doi: 10.1097/MCA.0000000000000860 URL |
[22] |
Morici N, Molinari V, Cantoni S, et al. Long-term risk of major adverse cardiovascular events in patients with acute coronary syndrome: prognostic role of complete blood cell count[J]. Angiology, 2020, 71(9):831-839.
doi: 10.1177/0003319720938619 URL |
[23] |
Kalra PR, Greenlaw N, Ferrari R, et al. Hemoglobin and change in hemoglobin status predict mortality, cardiovascular events, and bleeding in stable coronary artery disease[J]. Am J Med, 2017, 130(6):720-730.
doi: S0002-9343(17)30032-3 pmid: 28109968 |
[24] |
Erkan A, Ekici B, Uǧurlu M, et al. The role of bilirubin and its protective function against coronary heart disease[J]. Herz, 2014, 39(6):711-715.
doi: 10.1007/s00059-013-3872-5 pmid: 23861132 |
[25] |
Lai X, Fang Q, Yang L, et al. Direct, indirect and total bilirubin and risk of incident coronary heart disease in the Dongfeng-Tongji cohort[J]. Ann Med, 2018, 50(1):16-25.
doi: 10.1080/07853890.2017.1377846 URL |
[26] |
Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories[J]. Circulation, 1998, 97(18):1837-1847.
doi: 10.1161/01.cir.97.18.1837 pmid: 9603539 |
[27] |
Hannan EL, Samadashvili Z, Cozzens K, et al. Appro-priateness of diagnostic catheterization for suspected coro-nary artery disease in New York State[J]. Circ Cardiovasc Interv, 2014, 7(1):19-27.
doi: 10.1161/CIRCINTERVENTIONS.113.000741 URL |
[28] | Luciano LSC, Silva RLD, Londero Filho OM, et al. Ana-lysis of the appropriate use criteria for coronary angiog-raphy in two cardiology services of southern brazil[J]. Arq Bras Cardiol, 2019, 112(5):526-531. |
[1] | 丁燕飞, 忻笑容, 周郁芬, 谢玲, 谷雷雷, 吴云林, 陈平. 上消化道溃疡伴出血患者溃疡愈合延迟的危险因素分析[J]. 诊断学理论与实践, 2022, 21(03): 312-316. |
[2] | 张红, 朱梦梦. 新型冠状病毒肺炎疫情期间老年人进食安全护理[J]. 诊断学理论与实践, 2022, 21(02): 277-280. |
[3] | 梁亚丽, 赵海港, 项广宇. 应激性高血糖比值预测急性缺血性脑卒中患者溶栓治疗后1年不良预后的价值[J]. 诊断学理论与实践, 2021, 20(06): 562-566. |
[4] | 刘安平, 凌枫, 史超, 孙璟. 上海社区老年脑卒中患者跌倒风险因素分析及风险识别模型的建立[J]. 诊断学理论与实践, 2021, 20(05): 475-479. |
[5] | 施仲伟. 回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读[J]. 诊断学理论与实践, 2021, 20(04): 349-355. |
[6] | 林雨轩, 赵延华, 王筱婧. 丙泊酚镇静下无痛胃镜术中低氧血症的发生率及危险因素分析[J]. 诊断学理论与实践, 2020, 19(06): 594-599. |
[7] | 吴霖, 郑戈, 陶婷. ACE基因多态性与老年人肾功能下降的相关性研究[J]. 诊断学理论与实践, 2019, 18(2): 204-208. |
[8] | 侯亚楠, 禤立平, 赵志云, 李勉, 陈宇红, 戴蒙, 徐敏, 毕宇芳, 王卫庆, 高金丽. 上海社区中老年人群血尿酸/肌酐比值与代谢综合征关联性的流行病学调查[J]. 诊断学理论与实践, 2019, 18(1): 44-50. |
[9] | 魏晓敏, 张媛媛, 董樑, 夏敬文, 龚益, 喻永平, 李圣青. 真实世界中肺栓塞后慢性血栓栓塞性肺动脉高压的发病及相关危险因素前瞻性研究[J]. 诊断学理论与实践, 2019, 18(1): 37-43. |
[10] | 吴雪妍, 马丽娜, 程棣, 杜瑞, 徐瑜, 徐敏, 陆洁莉, 陈宇红, 毕宇芳, 王卫庆, 高金丽, 钱晓忠. 上海市宝山区淞南社区中老年人群静息心率与糖尿病相关性的流行病学调查[J]. 诊断学理论与实践, 2018, 17(01): 45-50. |
[11] | 周妍, 顾祎. 血清维生素D水平与老年人社区获得性肺炎严重程度的相关性研究[J]. 诊断学理论与实践, 2017, 16(06): 612-616. |
[12] | 王翠霞, 章晓炎, 巩云霞, 吴方. 老年人骨代谢状态指标与动脉粥样硬化性疾病的相关性研究[J]. 诊断学理论与实践, 2017, 16(06): 633-638. |
[13] | 王琳琳, 祝程诚, 张庆五, 陈婷, 吴舜. 血清PCT、IL-6、CRP水平在老年社区获得性肺炎鉴别诊断中的价值[J]. 诊断学理论与实践, 2017, 16(05): 532-536. |
[14] | 张诗, 何慧静, 万国斌. 200名晚期早产儿的盖塞尔婴幼儿智能评估量表的测试分析[J]. 诊断学理论与实践, 2017, 16(02): 217-220. |
[15] | 周嘉, 罗悦玲, 李励, 冼晶, 梁杏欢, 黄振兴, 秦映芬, 罗佐杰,. 广西40岁以上人群代谢综合征及其危险因素调查[J]. 诊断学理论与实践, 2016, 15(04): 364-370. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||